CENTR & CENTR Sugar Free a Hit at Mar-Val Food Stores
Vancouver, British Columbia--(Newsfile Corp. - September 30, 2021) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) today announced...
Year: 2021
CBD of Denver Retires Preferred Shares Early, Eliminates Potential Equity Dilution
Denver, Colorado--(Newsfile Corp. - September 30, 2021) - CBD of Denver, Inc. (OTC Pink: CBDD), a full-line CBD and hemp...
Greater Houston Healthconnect Uses InterSystems HealthShare® to Create Largest Known COVID-19 Outcomes Study
GHH has assembled a cohort of more than one million COVID-19 positive cases with all associated medical histories for outcomes...
Powell Recovery Center Chooses Netsmart: Advancing EHR Platform to Better Serve Public Health and Combat Opioid Crisis
OVERLAND PARK, Kan.--(BUSINESS WIRE)--#BehavioralHealth--Powell Recovery Center, a leading substance abuse treatment provider in Baltimore has chosen Netsmart to advance their...
Hologic Expands its Omni® Hysteroscopy Offering in Europe
New Omni 30° hysteroscope, Omni Lok cervical seal and Omni 5 French seal provide increased flexibility to support physicians both...
Accenture Named a Leader in the IDC MarketScape: Worldwide Life Science R&D BPO Services 2021 Vendor Assessment
NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) has been named a Leader in life science research and development (R&D) and business process...
41% of UK employees say workplace has negatively impacted wellbeing during pandemic
Majority of employees feel worse when it comes to wellbeing compared to 2019, and 33% believe they will be tired...
AlzeCure Presents at Vator Healthcare Innovation Summit on October 7
STOCKHOLM, SE / ACCESSWIRE / September 30, 2021 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company...
Nomination Committee of XVIVO Perfusion AB (publ)
GOTHENBURG, SE / ACCESSWIRE / September 30, 2021 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)The following members have been appointed to XVIVO...
Cybeats Addresses the Electric Vehicle Security and Charging Station Markets; Relay Comments on Mandated Software Requirements for EV Manufacturing and Infrastructure via SBOM
Toronto, Ontario--(Newsfile Corp. - September 29, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the...
MedTech Innovator Names Alva Health as 2021 Global Competition Winner at The MedTech Conference
Startup Receives $350K Grand Prize for Real-Time, Wearable Stroke Monitor for Older Americans Living with High Stroke Risk LOS ANGELES...
Scientific Industries to Present at the Lytham Partners Fall 2021 Investor Conference
BOHEMIA, NY and PITTSBURGH, PA / ACCESSWIRE / September 29, 2021 / Scientific Industries, Inc. (OTCQB:SCND) announced today that it...
Promaxo Announces Financing Agreement with Kineo to Support Growth Plans
OAKLAND, Calif.--(BUSINESS WIRE)--Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced an asset...
CAGW Releases Issue Brief on the Dangers of Government-Run Healthcare
WASHINGTON--(BUSINESS WIRE)--#GovWaste--Today, Citizens Against Government Waste (CAGW) released a new Issue Brief, “Government-Run Healthcare Will Harm Patients and Eliminate Consumer...
UTILITY Therapeutics to Present Data at IDWeek 2021
LONDON, UK / ACCESSWIRE / September 29, 2021 / UTILITY therapeutics Ltd., a biotechnology company focused on the US development...
iZafe Group nominated to win the award Golden Pill 2021
STOCKHOLM, SE / ACCESSWIRE / September 29, 2021 / iZafe Group (STO:IZAFE-B)iZafe Group AB (publ.) announces that for the second...
All Endpoints Met in Hepion Pharmaceuticals’ Drug-Drug Interaction Study with CRV431
EDISON, N.J., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial...
Denali Therapeutics Announces Upcoming Presentations on EIF2B Activator DNL343 and RIPK1 Inhibitor SAR443820/DNL788 at the 2021 Annual Northeast Amyotrophic Lateral Sclerosis (NEALS) Meeting
Denali to present results from Phase 1 healthy volunteer study of EIF2B activator DNL343Sanofi to present Phase 2 study plans...
Editas Medicine Announces Positive Initial Clinical Data from Ongoing Phase 1/2 BRILLIANCE Clinical Trial of EDIT-101 for LCA10
No serious adverse events or dose-limiting toxicities observed to date Efficacy signals in the mid-dose cohort provide initial support for...
TNFα-supplemented DL-4 culture system supports first-in-clinic Smart Immune ProTcell™ technology for immuno-deficient patients fighting cancers and infections
Rapid reset of immune system can provide marked benefits in clinical settings where patients are significantly immunocompromisedPARIS, Sept. 29, 2021...